Biotika a.s. (BSSE:1BSL01AE)
Slovakia flag Slovakia · Delayed Price · Currency is EUR
9.00
0.00 (0.00%)
At close: Aug 6, 2025

Biotika a.s. Statistics

Total Valuation

Biotika a.s. has a market cap or net worth of EUR 6.30 million. The enterprise value is 4.12 million.

Market Cap 6.30M
Enterprise Value 4.12M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Biotika a.s. has 700,000 shares outstanding.

Current Share Class 564,936
Shares Outstanding 700,000
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) 0.04%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.55
PB Ratio 0.25
P/TBV Ratio 0.25
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.30
EV / Sales 0.36
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -2.36

Financial Position

The company has a current ratio of 3.63

Current Ratio 3.63
Quick Ratio 1.15
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -4.84% and return on invested capital (ROIC) is -4.26%.

Return on Equity (ROE) -4.84%
Return on Assets (ROA) -3.76%
Return on Invested Capital (ROIC) -4.26%
Return on Capital Employed (ROCE) -6.79%
Revenue Per Employee 58,351
Profits Per Employee -6,345
Employee Count 197
Asset Turnover 0.39
Inventory Turnover 2.17

Taxes

Income Tax -140,870
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -55.00% in the last 52 weeks. The beta is -0.01, so Biotika a.s.'s price volatility has been lower than the market average.

Beta (5Y) -0.01
52-Week Price Change -55.00%
50-Day Moving Average 17.06
200-Day Moving Average 25.49
Relative Strength Index (RSI) 34.62
Average Volume (20 Days) 32

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Biotika a.s. had revenue of EUR 11.50 million and -1.25 million in losses. Loss per share was -1.79.

Revenue 11.50M
Gross Profit -772,030
Operating Income -1.76M
Pretax Income -1.39M
Net Income -1.25M
EBITDA -436,486
EBIT -1.76M
Loss Per Share -1.79
Full Income Statement

Balance Sheet

The company has 2.18 million in cash and n/a in debt, giving a net cash position of 2.18 million or 3.11 per share.

Cash & Cash Equivalents 2.18M
Total Debt n/a
Net Cash 2.18M
Net Cash Per Share 3.11
Equity (Book Value) 25.23M
Book Value Per Share 36.04
Working Capital 6.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -779,425 and capital expenditures -969,683, giving a free cash flow of -1.75 million.

Operating Cash Flow -779,425
Capital Expenditures -969,683
Free Cash Flow -1.75M
FCF Per Share -2.50
Full Cash Flow Statement

Margins

Gross margin is -6.72%, with operating and profit margins of -15.29% and -10.87%.

Gross Margin -6.72%
Operating Margin -15.29%
Pretax Margin -12.10%
Profit Margin -10.87%
EBITDA Margin -3.80%
EBIT Margin -15.29%
FCF Margin n/a

Dividends & Yields

Biotika a.s. does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -19.84%
FCF Yield -27.76%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Biotika a.s. has an Altman Z-Score of 4.34 and a Piotroski F-Score of 2.

Altman Z-Score 4.34
Piotroski F-Score 2